Group 1 - Company has been recognized as a national-level "specialized, refined, distinctive, and innovative" small giant enterprise by the Ministry of Industry and Information Technology, which enhances its brand recognition and industry influence [1][2] - The company specializes in chemical pharmaceutical raw materials and intermediates, which are crucial components of the pharmaceutical manufacturing industry, positioned upstream in the supply chain [1] - The company has cultivated a range of high-market-share products, including Sulfate Aluminum, Paracetamol, Atorvastatin Calcium, and PHBA, while expanding sales and market share for products like Escitalopram Oxalate and Parecoxib Sodium in recent years [1] Group 2 - The company has over 20 years of experience in the pharmaceutical industry, focusing on innovation, quality control, and reliable commercial reputation, which strengthens its core competitiveness and market influence [2] - The company has received multiple honors, including recognition as a "specialized and innovative" small enterprise in Zhejiang Province and various awards for quality and contribution to the local economy [2] - The company emphasizes technological innovation and has established a technical innovation system, collaborating with research institutions and universities to enhance R&D capabilities and market value realization [3] Group 3 - The company is committed to continuous R&D, production, and promotion of excellent pharmaceutical products and services, aiming to improve the quality of life [3] - The company plans to focus on the R&D, production, and sales of chemical pharmaceutical raw materials, intermediates, and formulations, pursuing a specialized development path [3] - The establishment of a pilot workshop will create an industrial R&D platform, facilitating the scaling up of new products and enhancing production capacity [3]
巩固强化核心竞争力 海森药业被认定为国家级专精特新“小巨人”企业